Bank of America’s XBiotech XBIT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $86.2K | Buy |
36,689
+794
| +2% | +$1.92K | ﹤0.01% | 5546 |
|
|
2025
Q4 | $85.8K | Sell |
35,895
-11,494
| -24% | -$28.3K | ﹤0.01% | 5673 |
|
|
2025
Q3 | $126K | Buy |
47,389
+29,181
| +160% | +$86.4K | ﹤0.01% | 6498 |
|
|
2025
Q2 | $54.1K | Buy |
18,208
+5,344
| +42% | +$15.5K | ﹤0.01% | 6783 |
|
|
2025
Q1 | $41.7K | Sell |
12,864
-7,024
| -35% | -$24.2K | ﹤0.01% | 6796 |
|
|
2024
Q4 | $78.6K | Buy |
19,888
+5,887
| +42% | +$40.1K | ﹤0.01% | 6499 |
|
|
2024
Q3 | $108K | Buy |
14,001
+3,638
| +35% | +$23.9K | ﹤0.01% | 6299 |
|
|
2024
Q2 | $53.3K | Buy |
10,363
+1,673
| +19% | +$12.9K | ﹤0.01% | 6497 |
|
|
2024
Q1 | $70.7K | Sell |
8,690
-4,668
| -35% | -$26.8K | ﹤0.01% | 6399 |
|
|
2023
Q4 | $53.4K | Sell |
13,358
-397
| -3% | -$1.58K | ﹤0.01% | 6577 |
|
|
2023
Q3 | $56.7K | Hold |
13,755
| – | – | ﹤0.01% | 6462 |
|
|
2023
Q2 | $81.7K | Sell |
13,755
-355
| -3% | -$1.6K | ﹤0.01% | 6279 |
|
|
2023
Q1 | $48.7K | Sell |
14,110
-4,624
| -25% | -$17.2K | ﹤0.01% | 6520 |
|
|
2022
Q4 | $65.8K | Buy |
18,734
+11,391
| +155% | +$38.8K | ﹤0.01% | 6396 |
|
|
2022
Q3 | $27K | Sell |
7,343
-10,166
| -58% | -$47.9K | ﹤0.01% | 6926 |
|
|
2022
Q2 | $98K | Sell |
17,509
-1,772
| -9% | -$11.9K | ﹤0.01% | 6480 |
|
|
2022
Q1 | $167K | Sell |
19,281
-33,989
| -64% | -$341K | ﹤0.01% | 6572 |
|
|
2021
Q4 | $593K | Buy |
53,270
+18,267
| +52% | +$238K | ﹤0.01% | 5714 |
|
|
2021
Q3 | $453K | Buy |
35,003
+27,927
| +395% | +$445K | ﹤0.01% | 5730 |
|
|
2021
Q2 | $117K | Sell |
7,076
-15,076
| -68% | -$256K | ﹤0.01% | 6431 |
|
|
2021
Q1 | $381K | Buy |
22,152
+14,652
| +195% | +$274K | ﹤0.01% | 5585 |
|
|
2020
Q4 | $117K | Sell |
7,500
-13,906
| -65% | -$256K | ﹤0.01% | 5904 |
|
|
2020
Q3 | $409K | Buy |
21,406
+13,107
| +158% | +$226K | ﹤0.01% | 4865 |
|
|
2020
Q2 | $114K | Sell |
8,299
-268,464
| -97% | -$3.77M | ﹤0.01% | 5611 |
|
|
2020
Q1 | $2.94M | Buy |
276,763
+262,426
| +1,830% | +$4.27M | ﹤0.01% | 3172 |
|
|
2019
Q4 | $268K | Sell |
14,337
-1,380
| -9% | -$17.8K | ﹤0.01% | 5437 |
|
|
2019
Q3 | $165K | Buy |
15,717
+1,559
| +11% | +$12.7K | ﹤0.01% | 5777 |
|
|
2019
Q2 | $107K | Sell |
14,158
-1,090
| -7% | -$9.48K | ﹤0.01% | 5975 |
|
|
2019
Q1 | $168K | Buy |
15,248
+11,947
| +362% | +$96.9K | ﹤0.01% | 5610 |
|
|
2018
Q4 | $17K | Buy |
3,301
+2,367
| +253% | +$9.71K | ﹤0.01% | 6526 |
|
|
2018
Q3 | $3K | Sell |
934
-10,692
| -92% | -$41.7K | ﹤0.01% | 6971 |
|
|
2018
Q2 | $52K | Buy |
11,626
+10,153
| +689% | +$45.9K | ﹤0.01% | 6125 |
|
|
2018
Q1 | $8K | Sell |
1,473
-16,758
| -92% | -$77.2K | ﹤0.01% | 6676 |
|
|
2017
Q4 | $72K | Buy |
18,231
+8,202
| +82% | +$34.5K | ﹤0.01% | 5897 |
|
|
2017
Q3 | $44K | Buy |
10,029
+4,508
| +82% | +$21.3K | ﹤0.01% | 5998 |
|
|
2017
Q2 | $26K | Sell |
5,521
-6,341
| -53% | -$60.7K | ﹤0.01% | 6140 |
|
|
2017
Q1 | $196K | Buy |
11,862
+8,354
| +238% | +$109K | ﹤0.01% | 5326 |
|
|
2016
Q4 | $35K | Buy |
3,508
+2,751
| +363% | +$36.6K | ﹤0.01% | 6087 |
|
|
2016
Q3 | $10K | Sell |
757
-1,516
| -67% | -$22.2K | ﹤0.01% | 6398 |
|
|
2016
Q2 | $48K | Buy |
+2,273
| New | +$32.8K | ﹤0.01% | 5849 |
|
|
2016
Q1 | – | Sell |
-5,264
| Closed | -$57K | – | 7354 |
|
|
2015
Q4 | $57K | Buy |
5,264
+5,235
| +18,052% | +$66.8K | ﹤0.01% | 5990 |
|
|
2015
Q3 | $0 | Sell |
29
-82
| -74% | -$1.44K | ﹤0.01% | 7433 |
|
|
2015
Q2 | $2K | Buy |
+111
| New | +$2.3K | ﹤0.01% | 7060 |
|
Other funds holding XBIT
VCM
RC
BCM
VFT
Bank of America's XBIT Position: Q1 2026 in Review
Bank of America increased its XBiotech (XBIT) stake by 2.2% in Q1 2026, buying an estimated $1.92K and bringing the position to 36,689 shares worth $86.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5546.
Bank of America first reported a position in XBIT in Q2 2015 and has held it in 43 quarters since. The position peaked at $2.94M in Q1 2020. 37 funds tracked by Wall St. Rank hold XBIT as of Q1 2026.
- Bank of America held 36,689 shares of XBiotech worth $86.2K as of Q1 2026.
- Bank of America bought 794 XBiotech shares in Q1 2026, an estimated $1.92K.
- XBiotech made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #5546 holding.
- Bank of America first reported a position in XBiotech in Q2 2015 and has held it in 43 quarters since.
- Bank of America's XBiotech position peaked at $2.94M in Q1 2020.
- 37 funds tracked by Wall St. Rank held XBiotech as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.